The Patent Finder

T Cell Receptors (2019)

Immunocore Limited

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/EP2018/066287, filed Jun 19, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,427,624T Cell Receptors
In force
 · High confidence
Immunocore LimitedIn force
High confidence
US 12,018,062T Cell Receptors
In force
 · High confidence
Immunocore LimitedIn force
High confidence
US 11,718,657T Cell Receptors
In force
 · High confidence
Immunocore LimitedIn force
High confidence
Application 18/664,825T Cell Receptors
Pending
Not granted
Immunocore LimitedPendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Immunocore Limited.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited